Gene tests could match advanced cancer patients to targeted therapies
NCT ID NCT02342158
First seen Apr 22, 2026 · Last updated Jun 13, 2026 · Updated 9 times
Summary
This study looked at whether analyzing the DNA of tumors from people with advanced or metastatic solid cancers could help doctors pick a targeted treatment. Over 550 patients had their tumor samples genetically tested. The goal was to see how many patients could be matched to a therapy based on their tumor's specific genetic changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASM METASTASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Paoli-Calmettes
Marseille, 13009, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.